arrow
G

Giancarlo Di Gennaro

irccs neuromed
H指数:35
被引数:4,437

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy

拉考沙胺在治疗12个月时的持续性高于布瓦雷萨坦和珀马panel,尽管其疗效相似。

2025-11-200
OAAI
Clinical factors associated with perampanel retention, response, seizure freedom and tolerability: real-world evidence from the PERMIT Extension study

与帕瑞莫潘保留、应答、无癫痫发作和耐受性相关的临床因素:PERMIT扩展研究的真实世界证据

2025-11-080
OA
Lennox–Gastaut syndrome unveiled: Advancing diagnosis, therapies, and advocacy-insights from the Genoa International Workshop

Lennox–Gastaut综合征解析:诊断、疗法及倡导的进展——热那亚国际研讨会见解

2025-10-290
OAAI
Trends in epilepsy surgery in Italy before and after the COVID-19 pandemic: A nationwide study

意大利癫痫手术在COVID-19疫情前后的趋势:一项全国性研究

2025-07-280
OAAI
Adjunctive Brivaracetam in People with Epilepsy and Intellectual Disability: Evidence from the BRIVAracetam Add-On First Italian netwoRk Study
2025-03-010
OAAI
Distinguishing seizures in autoimmune limbic encephalitis from mesial temporal lobe epilepsy with hippocampal sclerosis: Clues of a temporal plus network
2024-12-010
PRE